Aziyo Biologics Inc. (AZYO): Price and Financial Metrics


Aziyo Biologics Inc. (AZYO): $6.72

-0.28 (-4.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AZYO Stock Summary

  • AZYO has a market capitalization of $73,216,181 -- more than approximately only 12.26% of US stocks.
  • Aziyo Biologics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 86.75% of US listed stocks.
  • AZYO's went public 1.47 years ago, making it older than merely 2.48% of listed US stocks we're tracking.
  • Stocks that are quantitatively similar to AZYO, based on their financial statements, market capitalization, and price volatility, are BDSX, RDHL, PRTK, HTGM, and SNES.
  • AZYO's SEC filings can be seen here. And to visit Aziyo Biologics Inc's official web site, go to www.aziyobiologics.com.

AZYO Valuation Summary

  • AZYO's EV/EBIT ratio is -7.1; this is 124.23% lower than that of the median Healthcare stock.
  • Over the past 47 weeks, AZYO's price/sales ratio has gone down 1.9.
  • Over the past 47 weeks, AZYO's price/sales ratio has gone down 1.9.

Below are key valuation metrics over time for AZYO.

Stock Date P/S P/B P/E EV/EBIT
AZYO 2021-08-31 1.7 5.6 -3.7 -7.1
AZYO 2021-08-30 1.7 5.6 -3.6 -7.1
AZYO 2021-08-27 1.7 5.5 -3.6 -7.0
AZYO 2021-08-26 1.7 5.7 -3.7 -7.2
AZYO 2021-08-25 1.7 5.5 -3.6 -7.0
AZYO 2021-08-24 1.7 5.6 -3.6 -7.1

AZYO Price Target

For more insight on analysts targets of AZYO, see our AZYO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $16.50 Average Broker Recommendation 1.5 (Moderate Buy)

AZYO Stock Price Chart Interactive Chart >

Price chart for AZYO

AZYO Price/Volume Stats

Current price $6.72 52-week high $10.55
Prev. close $7.00 52-week low $4.10
Day low $6.45 Volume 26,442
Day high $7.17 Avg. volume 9,662
50-day MA $6.45 Dividend yield N/A
200-day MA $6.23 Market Cap 91.12M

Aziyo Biologics Inc. (AZYO) Company Bio


Aziyo Biologics, Inc. operates as a biotechnology company which focuses on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties. It offers cardiac device envelope, vascular surgery, cardiothoracic repair, orthopedics and spine, sports medicine, dermal, and wound care. The company was founded on August 6, 2015 and is headquartered in Silver Spring, MD.


AZYO Latest News Stream


Event/Time News Detail
Loading, please wait...

AZYO Latest Social Stream


Loading social stream, please wait...

View Full AZYO Social Stream

Latest AZYO News From Around the Web

Below are the latest news stories about Aziyo Biologics Inc that investors may wish to consider to help them evaluate AZYO as an investment opportunity.

Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference

SILVER SPRING, Md., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the Company will participate in the upcoming 42nd Annual Cowen Health Care Conference. Date: Wednesday, March 9, 2022Format: Fireside chat and 1x1 meetings The fireside chat will be hosted at 12:50 p.m. ET. A live and arc

Yahoo | February 23, 2022

Aziyo Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022

SILVER SPRING, Md., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it plans to release its fourth quarter and full year 2021 earnings results after market close on Thursday, March 3, 2022. Management will host a conference call to review the Company’s financial performance starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast.

GlobeNewswire | February 17, 2022

All You Need to Know About Aziyo Biologics, Inc. (AZYO) Rating Upgrade to Buy

Aziyo Biologics, Inc. (AZYO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | February 14, 2022

Has Aziyo Biologics, Inc. (AZYO) Outpaced Other Medical Stocks This Year?

Here is how Aziyo Biologics, Inc. (AZYO) and Doximity (DOCS) have performed compared to their sector so far this year.

Yahoo | February 14, 2022

Stonegate Capital Partners Initiates Coverage on Aziyo Biologics, Inc. (NASDAQ:AZYO)

DALLAS, TX / ACCESSWIRE / January 18, 2022 / Aziyo Biologics, Inc. (NASDAQ:AZYO): The full report can be accessed by clicking on the following link: http://stonegateinc.

Yahoo | January 18, 2022

Read More 'AZYO' Stories Here

AZYO Price Returns

1-mo 6.84%
3-mo 17.38%
6-mo 7.01%
1-year -36.36%
3-year N/A
5-year N/A
YTD 6.67%
2021 -53.78%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6878 seconds.